Madar, László and Majoros, Viktória and Szűcs, Zsuzsanna and Nagy, Orsolya and Babicz, Tamás and Butz, Henriett and Patócs, Attila and Balogh, István and Koczok, Katalin (2023) Double Heterozygosity for Rare Deleterious Variants in the BRCA1 and BRCA2 Genes in a Hungarian Patient with Breast Cancer. International Journal of Molecular Sciences, 24 (20). No.-15334. ISSN 1422-0067
|
Text
ijms-24-15334-v2.pdf - Published Version Available under License Creative Commons Attribution. Download (627kB) | Preview |
Abstract
Hereditary breast cancer is most commonly attributed to germline BRCA1 and BRCA2 gene variants. The vast majority of BRCA1 and BRCA2 mutation carriers are single heterozygotes, and double heterozygosity (DH) is a very rare finding. Here, we describe the case of a BRCA1/BRCA2 double heterozygous female proband diagnosed with breast cancer. Genetic testing for hereditary breast and ovarian cancer revealed two pathogenic variants in the BRCA1 (c.5095C>T, p.(Arg1699Trp)) and in BRCA2 genes (c.658_659delGT, p.(Val220Ilefs*4)) in heterozygous form. None of the variants were founder Jewish mutations; to our knowledge, these rare deleterious variants have not been previously described in DH patients in the literature. The patient had triple-negative unilateral breast cancer at the age of 36 and 44 years. Based on family studies, the BRCA1 variant was maternally inherited.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | BRCA1; BRCA2; double heterozygosity; breast cancer |
Subjects: | R Medicine / orvostudomány > R1 Medicine (General) / orvostudomány általában R Medicine / orvostudomány > RC Internal medicine / belgyógyászat > RC0254 Neoplasms. Tumors. Oncology (including Cancer) / daganatok, tumorok, onkológia |
Depositing User: | Dr Henriett Butz |
Date Deposited: | 11 Sep 2024 13:51 |
Last Modified: | 11 Sep 2024 13:51 |
URI: | https://real.mtak.hu/id/eprint/204697 |
Actions (login required)
![]() |
Edit Item |